Trials / Sponsors / Kahr Medical
Kahr Medical
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 1 | 2022-01-13 |
| Active Not Recruiting | A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors Advanced Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer | Phase 1 / Phase 2 | 2020-10-07 |
| Withdrawn | Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Pati Lymphoma | Phase 1 / Phase 2 | 2018-04-01 |